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ABSTRACT
Inventorship disputes appear to be proliferating. This is not surprising in light of the 1993
relaxation of the standards for joint inventorship. Although the vast majority of claims fail,
the handful of cases indicating successful inventorship claims can be quite lucrative, which
makes it reasonable to expect the upward trend in number of cases to continue. Moreover, the
lack of clarity on certain key aspects of inventorship law is apt to encourage further claims.
This article begins, as a cautionary tale of sorts: an analysis of the unclear aspects of
inventorship law. This includes the as yet unresolved variations in caselaw as to the basic
standard for inventorship and as a result what can serve as a basis for an inventorship claim
and the fact that even under the predominant standard ambiguities exist over what and how a
contribution can be adequately shown. It then proceeds to analyze four common situations
that can present inventorship problems, and suggests practical steps to minimize exposure and
create a solid documentary record to defeat any later inventorship claims.
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I. INTRODUCTION
In June, 2006, musician Billy Preston died. 1 In various obituaries, along with
chronicling his work with the Rolling Stones and various blues musicians, his
participation as keyboardist at the end of the group collaboration between John,
Paul, George and Ringo was inevitably mentioned. In this regard, and indeed in the
headline of many of the obituaries, Mr. Preston's brief interaction led him to being
described as the "Fifth Beatle." 2 He was hardly the first person to be described this
way. 3 From early band members to self-promoting DJs, famous producers to roadies,
Indian gurus and sitar master Ravi Shankar, the appellation has been attached to
just about every person with a significant tie to the group. In fact, the claim is so
well-known and widespread that a Simpsons episode has the immortal Kwik-E-Mart
proprietor, Apu, claiming the title before launching into a butchered send up of
Sergeant Peppers' Lonely Hearts Club Band in front of a horrified Paul and Linda
4
McCartney.
Now, no one really considered Apu a Beatle. Likely, none of the others laying
claim to the "Fifth Beatle" moniker were really considered a full member. Certainly,
the rights to the core song catalog do not reflect any extra Beatles, with only two cowriting credits on individual songs. 5 But the varied uses of this term speak to one of
the undeniable side effects of success in just about any field of creative endeavorhangers on suddenly emerge, often with aggrandized views of their roles in bringing
about that success. Less commonly, though often depicted in stage and screen,
someone's legitimate contribution is not credited or misappropriated-with resulting
rancor and often litigation.
Collaborations resulting in patents are no different than other creative
endeavors. A line of cases speaks eloquently to the effects of success in sharpening
the hindsight of omitted collaborators. Time and again, successful patents lead to
claims of inventorship. While inventorship and ownership are technically distinct

*Adjunct Professor, Indiana University School of Law, Indianapolis, Indiana. The views
expressed are solely those of the author. The author would like to thank David Quick and Joseph
Jacobi for their fresh eyes and helpful comments, Donald Knebel for his mentorship and ideas on
conception of contribution, and his wife Lilia Teninty for putting up with him.
Available at http://www.jmripl.com
1 Tifth Beat]eBify Preston Dies at 59, MSNBC.COM,, http://www.msnbc.msn.com/id/13168091
(last visited Aug. 11, 2007) (discussing the June 6, 2006 passing of Billy Preston).
2 Id.

3_[d.
4 The Simpsons:Lisa the Vegetarian (FOX television broadcast Oct. 15, 1995).

5 See The Beatles with Billy Preston, Get Back/Don't Let Me Down (Capitol Records 1969)
(1969); The Beatles, The Beatles with Tony Sheridan and Guests (MGM Records 1961) (1964).
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issues, 6 the motivation for claiming inventorship is almost always a cut of ownership
and some form of damages (although sometimes it is an effort at rendering a patent
invalid, a disgruntled former employee with an axe to grind or a student looking for
recognition and a better shot at tenure). While the overwhelming majority of such
claims fail, victory for the patentee (or, more often, assignee) always comes at a price.
Where documents have been destroyed or where good documentation was never
created in the first place, and memories have faded over time, that cost can threaten
to outstrip the value of the patent. Moreover, the lucrative results in a few truly
egregious situations 7 have encouraged and continue to encourage a plethora of
claims. The stakes are likely to only get higher in the future.
The best way to deal with such problems, of course, is to do as much as possible,
as early as possible, to guard against the sort of fact situations that give rise to such
claims. The goal of this article is to provide a set of suggested practices that seek to
minimize errors in naming inventors and bolster the odds of a quick resolution to any
dispute. While no set of practices is fool-proof, these should at least empower most
practitioners to avoid the most costly and common mistakes.
To underscore the value of these practices, the article begins with an overview of
Federal Circuit inventorship law. As shown therein, while most recent cases have
adopted a single standard for resolving inventorship issues, there remains a
fundamental uncertainty as to what can be an inventive contribution. Even under
the predominant standard, several of the underlying determinations are based on
essentially open-ended criteria which may have little to no connection to the actual
efforts of the named inventors and unnamed collaborators. This further emphasizes
the value of avoiding, rather than litigating, co-inventorship problems.
Beyond this general uncertainty, the variety of situations that can result in coinventorship disputes should give every patent practitioner pause. Without trying to
address every potential scenario, this article endeavors to address the four fact
patterns (intra-company collaborations, inter-company collaborations, company
collaborations with universities, and mentor-student collaborations at universities)
that seem to pre-dominate the case law and suggest practical steps which can avoid
such disputes from arising, with particular emphasis on the unique attributes of each
scenario. Most, if not all, are simply common sense and generally good business
practices applied in a novel environment. However, as the case law shows, these
practices are often honored mainly in the breach, by parties who find themselves
spending time and money on legal assistance to address issues that basic good
manner and a slightly elevated sense of ethical conduct likely would have mooted. In
this regard, this article is intended as the ounce of prevention that may avoid pounds
of future "cure."

6 See Sewall v. Walters, 21 F.3d 411, 417 (Fed. Cir. 1994). The court noted:
It is elementary that inventorship and ownership are separate issues....
[I]nventorship is a question of who actually invented the subject matter claimed
in a patent. Ownership, however, is a question of who owns a legal title to the
subject matter claimed in a patent, patents having the attributes of personal
property.
_Td. (quoting Beech Aircraft Corp. v. EDO Corp., 990 F.2d 1237, 1248 (Fed. Cir. 1993)).
7 See, e.g., Univ. of Colo. Found. v. Am. Cyanimid, 342 F.3d 1298 (Fed. Cir. 2003) (affirming
verdict in excess of $50 million for unjust enrichment related to misrepresentations of inventorship).
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THE LESS THAN CLEAR LEGAL STANDARDS OF INVENTORSHIP

Indeed, the potential for inventorship claims poses a unique set of challenges to
patentees. Although the section authorizing courts to correct inventorship where
possible is written in a way that might suggest judicial action is only available in
cases seeking to otherwise invalidate a patent,8 it has been interpreted as providing
a basis for a free standing action for correction of inventorship arising under the
patent laws. 9 Therefore, these claims can be brought without any prior threat of
litigation or communication by the allegedly omitted party-the only prerequisite is
notice and an opportunity to be heard. 10 The Federal Circuit has suggested (without
having to decide) that such claims may even be brought by an alleged inventor who
has no pecuniary interest in the outcome based on the public interest and potential
reputational interests in proper inventorship. 11 There is no statute of limitations for
claims for correction of inventorship. 12 While a party can be found to be barred from
asserting such a claim based on equitable estoppel, the proof required is not
ordinarily available. 13 Along with such claims will often come state law actions for
unjust enrichment or even fraud, the latter of which may result in a finding the
patent is unenforceable due to inequitable conduct. 14 In fact, even if inventorship is
ultimately correct, misrepresentations regarding inventorship can still support a
15
finding of unenforceability.
Inventorship cases have a spotty history at the Federal Circuit, with most of the
case law arising in the last ten to fifteen years. This shouldn't be surprising, since
until the enactment of amendments to 35 U.S.C. § 116 in 199316 one had to be a coinventor of every claim to be named as an inventor on a patent. 17 However, in some
respects the case law surrounding the question of inventorship harkens back to Court
8 See 35 U.S.C. § 256,

2 (2006) (stating that errors "shall not invalidate the patent in which

such error occurred if it can be corrected" and "[t]he court before which such matter is called in
question may order correction of the patent on notice and hearing of all parties concerned ... .
9 MCV, Inc. v. King-Seeley Thermos Co., 870 F.2d 1568, 1570-71 (Fed. Cir. 1989).
10Id. at 1571; 35 U.S.C. § 256, 2.
11Chou v. Univ. of Chi., 254 F.3d 1347, 1357-59 (Fed. Cir. 2001).
12 See 35 U.S.C. § 256.
13See MCV 870 F.2d at 1571-74 (noting standard estoppel principles from infringement
applied and therefore required notice of the patent proceedings, a misleading misrepresentation and
detrimental reliance as well as finding that a party's "misleading nonchalance about its putative
right to co-inventorship" gave rise to estoppel).
14 Univ. of Colo. Found. v. Am. Cyanimid, 342 F.3d 1298, 1298 (Fed. Cir. 2003); Stark v.
Advanced Magnetics, Inc., 119 F.3d 1551, 1555-56 (Fed. Cir. 1997) (permitting both correction of
inventorship and state law fraud claims to move forward, but cautioning that fraud by named
inventors would likely render the patent unenforceable in hands of anyone).
15 See PerSeptive Biosystems, Inc. v. Pharmacia Bio-Tech., Inc., 225 F.3d 1315, 1321-22 (Fed.
Cir. 2000).
1635 U.S.C. § 116 (2006). 35 U.S.C. § 116 was passed to encourage and reward "team
research" and reads in pertinent part:
Inventors may apply for a patent jointly even though (1) they did not physically
work together at the same time, (2) each did not make the same type or amount of
contribution, or (3) each did not make a contribution to the subject matter of every
claim of the patent.

Id.
17 See Ethicon, Inc. v. U.S. Surgical Corp., 135 F.3d 1456, 1469-70 (Fed. Cir. 1998) (Newman,
J., dissenting in part).
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of Claims practices, the foundations of the doctrine of inequitable conduct, and on one
key evidentiary concept, nineteenth century Supreme Court case law. Two things
are clear from all of this case law: 1) courts are skeptical of such claims; and 2) as a
result, purported co-inventors (or those claiming defects in inventorship) lose such
disputes much more often than they win.

A. The Federal CircuitHas a Well-EstablishedBias Against Claims of
Joint or PriorInvention.
Well before the Federal Circuit got involved, the Court of Claims had indicated
that claims of joint or prior inventorship should be met with skepticism.1 8 "[Tihe
burden of showing misjoinder or nonjoinder of inventors is a heavy one and must be
proved by clear and convincing evidence." 19
The rule rests on important policy considerations ....
[T]here
is... [a] strong temptation for persons who consulted with the
inventor and provided him with materials and advice, to reconstruct,
so as to further their own position, the extent of their contribution to
the conception of the invention. In these circumstances, it would be
inappropriate to permit a lower standard than clear and convincing
20
evidence.
Additionally, the issuance of a patent creates a presumption that inventorship
21
is correct.
Hess itself is a good example of why caution must be exercised in analyzing
inventorship claims. This case actually grew from prior litigation in which the
validity of the balloon catheter patents held by Advanced Cardiovascular Systems
were asserted to be invalid for non-joinder of Mr. Hess as an inventor. 22 Mr. Hess
then sought to intervene and was initially dismissed. 23 Mr. Hess then proceeded to
24
lodge an independent action for such correction.
As reported in the case, Mr. Hess was a representative of a materials company
who advised the named inventors about the properties and characteristics of the
company's products for potential use in making a balloon catheter. 25 The product, in
turn, was used in the first embodiments of the invention and was mentioned in the

18 Hess

v. Advanced Cardiovascular Sys., Inc., 106 F.3d 976, 980 (Fed. Cir. 1997).

1) Id. (quoting Garrett Corp. v. United States, 422 F.2d 874, 880 (Ct. Cl. 1970), cert. denied

400 U.S. 951 (1970)).
20 Id. (noting that the concern with unfounded revisions of a party's involvement is particularly
justified "where, as here, the patent has been outstanding for a considerable time and the patented
device has been successful").
21 Ethicon, 135 F.3d at 1460; see also Bd. of Educ. ex relBd. of Tr. of Fla. State Univ. v. Am.
Bioscience, Inc., 333 F.3d 1330, 1337 (Fed. Cir. 2003); Trovan, Ltd. v. Sokymat SA, 299 F.3d 1292,
1301 (Fed. Cir. 2002).
22 Hess, 106 F.3d at 978-79.
23 d
24 Id
25

Id. at 977-78.
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specification. 26 Other suggestions by Mr. Hess were used by the named inventors in
the course of the development, but either not recited in the patent or not claimed.27
The district court and ultimately the Federal Circuit found that Mr. Hess was not an
inventor, but rather acted more like a salesperson in explaining qualities of a product
that was publicly available. 28 Hence, the knowledge provided by Mr. Hess was not
inventive. Moreover, he never actually conceived of the final product of the alleged
collaboration.29 It was against this backdrop that the court noted the tendency for
omitted persons to re-evaluate their positions through the lens of hindsight, as
sharpened by commercial success, and therefore justifying the requirement of clear
30
and convincing evidence to establish co-inventorship.
In evaluating the contributions of Mr. Hess, the Federal Circuit reached back to
the Supreme Court's treatment of Samuel Morse in determining the validity of his
patent on the telegraph. 31 In the Samue] Morse case, the Federal Circuit noted, the
consultation of Mr. Morse with learned persons in a number of fields did not and
should not cost him (or any other party) exclusive rights as the true inventor, any
more than reading a book on the subject to acquire background information would
have. 32 Similarly, although some things and general ideas that Mr. Hess had
conveyed to the named inventors made their way into the patent, that information
33
was not itself inventive.
In one other key respect, inventorship law reflects skepticism in the claims of
others.
Claims of co-inventorship, like claims of prior invention, must be
corroborated. 34 Corroboration is subject to a "rule of reason" analysis, based on all
relevant and admissible evidence other than the inventor's testimony. 35
The
requirement of corroboration to establish prior inventorship has been part of patent
law since at least the Barbed Wire Patent CaSe.36 Not every aspect of the assertion
has to be corroborated, but it must be sufficient to establish inventorship by clear and
convincing evidence. 37
Sources of corroboration can include contemporaneous
38
documentation, circumstantial evidence and even the oral testimony of others.
Corroboration is a stringent requirement. In Ethicon, while the lower court had
based its determination of inventorship largely on the credibility of the omitted
inventor, the key element was the existence of drawings of the embodiment in the
patent made by the omitted party in the possession of the named inventors. 39 Few

27 Id.
28

Id.at 980-81.

29 Id

'30
Id. at 980.
31 Id.at 981 (quoting O'Reilly v. Morse, 56 U.S. (1 How.) 62 (1853)).
32 Hess, 106 F.3d at 981 (quoting OReily, 56 U.S. at iii).
33 Hess, 106 F.3d at 980-81.
34 Gemstar-TV Guide Int'l, Inc. v. Int'l Trade Comm'n, 383 F.3d 1352, 1382-83 (Fed. Cir. 2004);
Linear Tech. Corp. v. Impala Linear Corp., 379 F.3d 1311, 1327 (Fed. Cir. 2004).
'35 Linear Tech. Corp., 379 F.3d at 1327; Gemstar-TV Guide Int'l, Inc., 383 F.3d at 1383.
3 Washburn & Moen Mfg. Co. v. Beat 'Em All Barbed-Wire Co., 143 U.S. 275, 287-90 (1892);
see also Woodland Trust v. Flowertree Nursery, Inc., 148 F.3d 1368, 1372 (Fed. Cir. 1998) (assessing
corroboration in context of claim of invalidity).
37 Ethicon, Inc. v. U.S. Surgical Corp., 135 F.3d 1456, 1464 (Fed. Cir. 1998).
3 _Id. at 1461.
39 Id.at 1461, 1464.
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cases ever present such clear documentation of contribution. By comparison, in Eli
Lilly and Co. v. Aradigm Corp.,40 the Federal Circuit reversed a jury verdict of joint
inventorship on the grounds of insufficient evidence of a contribution, owing in part
to a lack of corroboration for the asserted contribution. 41 In that case, a Lilly
employee (Dr. DiMarchi) was one of the named inventors of an artificial form of
insulin known as lispro. 42 This compound, patented in May 1996, was then
subsequently listed in two dependant claims as a compound for aerosol delivery of
insulin with improved bioavailability in a patent filed by Aradigm. 43 Prior to a
meeting in July 1996 between Aradigm representatives and Dr. DiMarchi, there was
no mention of lispro in the records of Aradigm, yet within six months of the meeting
the patent application reciting lispro by name was filed. 44 Nonetheless, despite
testimony from Dr. DiMarchi that he spoke about the improved bioavailability of
lispro in July, 1996, and that it was his habit to discuss lispro's characteristics
anytime insulin was discussed (as it was at the meeting with Aradigm), the Federal
Circuit found this was insufficient evidence of a contribution to the conception of the
claimed invention. 45 Rather, the evidence relating to the July meeting only proved a
suggestion that lispro be tried, rather than providing insight on the subsequently
claimed benefits of using the specific compound. 46 Coupled to the lack of specific
recall of Dr. DiMarchi's statements, and the fact that other scientists described their
own meetings with Aradigm more generally, the Federal Circuit found the requisite
47
act of contribution had not been established by clear and convincing evidence.
Hence, anyone seeking to attach themselves to a patent has an uphill, if not virtually
impossible, struggle.

B. Why Do Inventorship Claims Persistin the Face of This Bias?
Against this backdrop, one might wonder why such claims persist and seem to
have grown in recent years. The answer is simple-money. In the 1998 Ethicon
case, the Federal Circuit held that while section 116 had lowered the level of
contribution required to be a joint inventor, the presumption that all co-inventors
owned a patent in common had not been changed. 48 That is, while a person's claim
to inventorship may rest on a contribution to a single element of a single claim (or
two out of dozens as in Ethicon), in the absence of an agreement to the contrary,
inventor status entitles the individual to equal rights in the patent. 49 This is

376 F.3d 1352 (Fed. Cir. 2004).
Id. at 1363-64. In the name of full disclosure, Barnes & Thornburg LLP handled both the
trial and appeal of this case for Eli Lilly and Co. while the author was an associate, but the author
was not substantively involved in trial strategy or formulating the arguments on appeal.
42 Id. at 1355.
4 Id. at 1355-56.
44Id.at 1355, 1364.
45 Id. at 1363-64.
46 Id.
40
41

4

Id

48 Ethicon,
49 Id.

Inc. v. U.S. Surgical Corp., 135 F.3d 1456, 1465-66 (Fed. Cir. 1998).
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arguably the only sound reading of the first paragraph of section 26150 and section
262,51 which indicate "joint owners" are essentially holders in common of the patent.
Although this was a two-judge holding with a spirited dissent by Judge Newman on
the question of ownership (a mark of several other cases touching on inventorship
issues) no case since has challenged, or really questioned, its holding. This finding of
co-ownership, in turn, allowed the omitted inventor, by refusing to consent to an
infringement suit, to have the effect of blocking litigation by the inventor of the
remaining claims and hence making co-ownership extremely valuable. 52 If this
wasn't enough of an incentive, the holding in University of Colorado Foundation
affirming a $53 million unjust enrichment award stemming from misrepresentations
53
of inventorship certainly provided an incentive to bring even marginal claims.
An additional incentive to bringing such claims is the lack of clarity in
54
inventorship law. Although there is a presumption that inventorship is correct,
this does not mean all aspects of an inventorship analysis are stacked in the named
inventor's favor. The Federal Circuit's case law arguably supports several different
standards for assessing inventorship. Even within the standard typically used-a
substantial contribution to conception of the invention as measured by the issued
claims-a number of murky, fact intensive questions remain. 55 Assuming the
propriety of measuring contributions by a standard the omitted party had no input or
control over, determining inventorship at a minimum requires a court to indulge in
the ever-uncertain process of arriving at claim construction. Once this is done and
the court sets about comparing the alleged contribution against the construed claims,
it is unclear if a party needed to know how its contributions would be used in the
ultimate invention at the time of the contribution-that is, whether the party had to
conceive of his or her alleged contribution as ultimately claimed or merely show that
the claim or element can be traced back to the contributor's conduct.

1. Is There a ClearStandardfor Inventorshi ?
Most recent cases on inventorship act as if there is a single, set standard for
inventorship-"a contribution to the conception of the claimed invention that is not
5035 U.S.C. § 261,
1 (2006) (stating in its entirety, under the heading "Ownership;
assignment", that "[s]ubject to the provisions of this title, patents shall have the attributes of
personal property").
5135 U.S.C. § 262. That section, entitled "Joint owners" states:
In the absence of any agreement to the contrary, each of the joint owners of
a patent may make, use, offer to sell, or sell the patented invention within the
United States, or import the patented invention into the United States without
the consent of and without accounting to the other owners.
Id.
52 Ethion, 135 F.3d at 1466-68.
53 Univ. of Colo. Found. v. Am. Cyanamid Co., 342 F.3d 1298, 1312 (Fed. Cir. 2003).
54 35 U.S.C. § 282 (presumption of patent validity); 35 U.S.C. § 256 (requiring application from
"all parties and assignees" to obtain certificate correcting a patent with a missing inventor). See also
Trovan, Ltd. v. Sokymat SA, 299 F.3d 1292, 1301-02 (Fed. Cir. 2002) (holding section 282 presumes
that the named inventors "are the true and only inventors").
5 Fina Oil & Chem. Co. v. Ewen, 123 F.3d 1466, 1473 (Fed. Cir. 1997); see also Monsanto Co.
v. Kamp, 269 F. Supp. 818, 824 (D.D.C. 1967).
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insignificant in quality, when that contribution is measured against the dimension of
the full invention" 56 by resort to the claims. However, neither section 116 nor all the
case law support this narrow view. 57 Indeed, it is arguably contrary to the text of
section 116 to focus exclusively on conception, and relying on claims as the sole
benchmark of the invention. Thus, there may still be further developments on the
basic framework of inventorship in future cases that place an even greater premium
on avoiding such situations wherever possible.
In its dominant "contribution to conception" standard, the Federal Circuit is
extending a premise from section 102(g) that in determining priority of invention, a
prior conception trumps all later inventors so long as the reduction to practice was
"diligent."58 It is on this foundation that conception has been elevated to the
"touchstone of invention," which is the justification for using it as the starting point
of determining invention. 59 Conception, in turn, is the "formation in the mind of the
inventor, of a definite and permanent idea of the complete and operative invention,
as it is hereafter to be applied in practice." 60 Starting from this perspective, it only
logically follows that the claims (the actual, practical embodiment of the invention)
61
be used as the benchmark to measure contributions to conception.
In this logical chain, however, lies a potentially fatal flaw. Section 116 does not
speak to "conceiving" an invention jointly. Rather, it discusses the idea of "making"
an invention jointly. 62 As other case law and even section 102(g) make clear, an
63
invention is not "made" until it is both conceived and reduced to practice.
Therefore, it might be possible under the literal text of section 116 to be an inventor
based on a contribution to the reduction to practice.
This broader standard has been endorsed by at least two cases. In Pannu v.
blab Corp.,64 the question of inventorship, raised as a basis for invalidity, centered
on contributions to a replacement "intraocular lens," for use to replace failed natural
lenses (such as might happen from cataracts).65
In remanding for further
consideration, the Federal Circuit did not limit the district court's inventorship
analysis to contributions to conception, alone; the district court could also consider
significant contributions to a reduction to practice. 6 6 Similarly, in Board of

56 Fina Oil, 123 F.3d at 1473. See also Caterpillar, Inc. v. Sturman Indus., Inc., 387 F.3d 1358,
1377 (Fed. Cir. 2004) (quoting Fina O/l; Sewall v. Walters, 21 F.3d 411, 415 (Fed. Cir. 1994);
Burroughs Wellcome Co. v. Barr Labs., Inc., 40 F.3d 1223, 1227-28 (Fed. Cir. 1994); C.R. Bard, Inc.
v. M3 Sys., Inc., 157 F.3d 1340, 1352 (Fed. Cir. 1998); Eli Lilly & Co. v. Aradigm Corp., 376 F.3d
1352, 1358-59 (Fed. Cir. 2004).
57 35 U.S.C. § 116.
58 Id. § 102(g).
59 Ethicon, Inc. v. U. S. Surgical Corp., 135 F.3d 1456, 1460 (Fed. Cir. 1998); Trovan, 299 F.3d
at 1302.
60Trovan, 299 F.3d at 1302 (quoting Hybritech Inc. v. Monoclonal Antibodies, Inc., 802 F.2d
1367, 1376 (Fed. Cir. 1986)).

(1 Trovan, 299 F.3d at 1302; Eticon, 135 F.3d at 1460.
62

35 U.S.C. § 116.

Id. § 102(g); Dow Chem. Co. v. Astro-Valcour, Inc., 267 F.3d 1334, 1339-40 (Fed. Cir. 2001).
(34155 F.3d 1344 (Fed. Cir. 1998).
(3 Id. at 1346.
(36Td. at 1351. The court also noted that in the event any party is added, it may lead to a
63

violation of the best mode requirement depending on the views of the omitted inventor. Id. at 1351
n.5.
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Education v. American Bioscience, Inc., 67 a dispute arose over the inventorship of a
series of taxol analog compounds. 68 Among other things, a district court had
awarded inventorship based on the supposed use of confidential techniques to reduce
the claimed compounds to practice. 69 The Federal Circuit rejected this on the
grounds that the techniques were not claimed in the patent and had not been shown
to be necessary to producing the compounds in question.70 Nonetheless, the panel
did state that if the assistance of the creator of the techniques had proven necessary
to make previously conceived compounds, he "might have been a coinventor." 71 Thus,
at least under some circumstances there would seem to be a basis for expanding
inventorship beyond contributions to conception.72
Of course, it would be an error to read too much into Pannu. Many claims are
only constructively reduced to practice by virtue of filing a patent application. In
doing so, the patent attorney may add details or limitations that the inventor's
subjective conception did not embrace or recognize as significant aspects of the
invention. Moreover, the language employed may not track what the inventor would
have originally used to describe the invention.7 3 This sort of disconnect is why in the
context of claim construction, an inventor's testimony is generally given little or no
weight, and inventors are not even required to be able to describe their inventions in
7
the terms employed in patent claims.

4

While such a failure of description may seem far-fetched, it is at the heart of
Solomon v. i'mberly-Clark Corp.75 In that case, during the course of a deposition
the named inventor identified a particular prototype structure as reflecting her
inventive feminine hygiene product. The prototype in question, though, lacked a
"depression" as that claim term had been construed. 76 The defendant asserted that
these claims were invalid due to a defect of inventorship, with an implicit assertion
that the patent attorney who supplied the remaining elements should have been
77
named as an inventor, and could not claim the omission was accidental.
Ultimately, the Federal Circuit affirmed the court below in rejecting this claim as
67 333
68

F.3d 1330 (Fed. Cir. 2003).
Id. at 1332-33. Taxols, and the related taxotere compounds at issue in this case are derived

from yew trees and have proven useful in cancer treatments. d
6 Id. at 1341.
70 Id. at 1341-42 n.6.
71 Id. at 1342.
2 Alternatively, however, one can at least harmonize American Bioscience with most cases; if
the technique in question was truly necessary, then arguably the invention could not be completely
conceived of-that is, have both a structure and a method of production-without the technique. Id.
at 1341-42 (discussing Burroughs Wellcome Co. v. Barr Labs., Inc., 40 F.3d 1223, 1229 (Fed. Cir.
1994)). However, Pannu has no such limitation of necessity and even American Bioscience is
internally contradictory on this issue. Compare Pannu v. Iolab Corp, 155 F.3d 1344, 1351 (Fed. Cir.
1998) with Am. Bioscience, 333 F.3d at 1341-42.
73 Ethicon, Inc. v. U.S. Surgical Corp., 135 F.3d 1456, 1465 (noting that "a layman, untrained
in the language of the patent law, may reasonably err in interpreting claim language"); see also
Markman v. Westview Instruments, Inc. (Markman 1),52 F.3d 967, 971 (Fed. Cir. 1995) (en banc),
affdon other grounds, (Markman I), 517 U.S. 370 (1996) (rejecting inventor's testimony on subject
of "inventory").
74Markman j 52 F.3d at 985.
75216 F.3d 1372 (Fed. Cir. 1999).
76 Id.at 1376.
77
Id. at 1380-81.
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there was no evidence of inventorship by a third party, rather than a disconnect
between the inventor's understanding of her invention and the legally construed
scope of the same.7 8 The Federal Circuit, concerned with the policy implications of
converting patent lawyers into inventors, also stated that any broadening of the idea
by the attorney was simply the job of counsel rather than a basis for finding a defect
of inventorship.7 9 The panel also noted the general lack of value of an inventor's
subjective views to claim scope, owing in part to the significant changes that might
80
take place from an inventor's initial conception through issuance.
While noble in its desire to protect both patent attorneys from rampant conflicts
of interest and inventors from having their patents invalidated anytime counsel is
not named a co-inventor, Kimberly-Clark raises significant questions about the
soundness of the prevailing standard for determining inventorship. If claims are not
to be interpreted based on the understanding of inventors, and are not even expected
to be written in language inventors can necessarily comprehend, then the logic of
measuring the existence and substance of a party's contributions by the claims loses
most, if not all, of its intuitive force. Moreover, in light of Solomon and Markman'
recognition of the reality that claims are routinely amended and altered in ways that
reflect the thinking of patent attorneys and patent examiners rather than the
original conception of the inventor, by the time of final issue a claim set may bear
little to no resemblance to the work done by the original collaborative team.8 1 In
effect, a legitimately omitted inventor is placed in the position of first translating his
or her contribution into claim language (or claim language into terms more closely
approximating his or her own subjective understanding of the technology) and then
establishing the significance of the same while the named inventor is not expected to
appreciate the significance of any aspect of the claim in the first instance.
Additionally, section 116 does not by its terms require a contribution to any
particular claim. In fact, it states that joint inventors do not each have to "make a
contribution to the subject matter of every claim of the patent."8 2 On the one hand,
this had the intended result of removing the prior requirement of joint inventorship
of every claim in a patent. As written, however, there is no legal lower threshold on
the number of claims that a party needs to have made a contribution to.
Additionally, section 116 is technically about inventorship status at the time of filing
the application, not subsequent amendments. Even if the statute was therefore read
as requiring a contribution to at least one claim to support the naming of an inventor
in an application, it may not technically require a contribution to an ultimately
78 Id.
7

at 1381-82.

Id.at 1382.

80 Id.at 1379-80 (quoting Markman v. Westview Instruments, Inc. (Markman 1),52 F.3d 967,
985 (Fed. Cir. 1995).
SI Id.at 1379. The court, quoting Markman I stated:
Commonly the claims are drafted by the inventor's patent solicitor and they may
even be drafted by the patent examiner in an examiner's amendment (subject to
the approval of the inventor's solicitor). While presumably the inventor has
approved any changes to the claim scope that have occurred via amendment
during the prosecution process, it is not unusual for there to be a significant
difference between what an inventor thinks his patented invention is and what
the ultimate scope of the claims is after allowance by the PTO.
Id. (quoting Markman 1 52 F.3d at 985).
82

35 U.S.C. § 116 (2006).
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issued claim to support inventorship. Nonetheless, the Federal Circuit has drawn
the line at basing inventorship on cancelled claims-although it has permitted
alleged misrepresentations about the inventorship of the claims as filed to support a
finding of inequitable conduct. 83
While the foregoing demonstrates that the current standards are not as
monolithic as recent cases might suggest, it should not be read as rejecting the
prevailing "contribution to conception" regime in its entirety. Using claim language
at least places some meaningful boundaries on the question of inventorshipotherwise, the inquiry could devolve into a game of "but for" causation on a par with
"[fior want of a nail ... the Kingdom was lost." 84 Although claim construction may
not always lead to a perfect assessment of whether a contribution was significant
from the perspective of a general collaboration, it will generally lead to a meaningful
assessment of the significance of a contribution to the overall value of the patent as a
piece of personal property consistent with section 261-assuming, of course, the
claim construction is correct. Moreover, while the extremes of situations like
Kiimberly-Clark exist, they are rare. Patent attorneys normally aspire to speak in
the lingua franca of inventors, rather than purely as technocratic attorneys. Most
purportedly omitted inventors are all too ready to assert contributions reflected in
the claims, and can find experts to support their assertions. Hence, given the focus of
this article on practical assistance rather than construction of a hypothetical ideal for
assessing inventorship, for the duration of this article it is assumed that the Federal
Circuit's prevailing standard of a significant contribution to conception will be
85
applied to any inventorship dispute.

2. Assuming Contributions To Conception Are A]] That Count Leaves Certain Issues
Unresolved.
If a "not insignificant" contribution to the conception of an invention is assumed
to be the only way to be an inventor, the precedent of the Federal Circuit includes at
least two further areas of uncertainty for anyone bringing or defending an action for
correction of inventorship. The first is the Federal Circuit's embrace of claim
construction as the basis for determining the scope of the conception of the
invention.86 While nominally a question of law, the rampant uncertainty over claim
construction generally and the underlying malleability of language does nothing to
discourage unscrupulous parties coming to an invention after the fact from asserting
inventorship. At the same time, adopting this framework may very well defeat
83 Bd. of Educ. v. Am. Bioscience, Inc., 333 F.3d 1330, 1342 n.7 (Fed. Cir. 2003) ("Nonetheless,
it is the granted patent with the limited claims that is before us, and any possible inventorship with
respect to the cancelled claims is not at issue here."); PerSeptive Biosystems, Inc. v. Pharmacia BioTech., Inc., 225 F.3d 1315, 1322 (Fed. Cir. 2000) (rejecting assertion that narrowing claims in
prosecution made any misstatements regarding inventorship immaterial).
84 United States v. Chhien, 266 F.3d 1, 7 (1st Cir. 2001) (analogizing to The Real Mother Goose
82-104 (1916)).
85Fina Oil & Chem. Co. v. Ewen, 123 F.3d 1466, 1473 (Fed. Cir. 1997) (noting a joint inventor
must contribute in some significant manner to the conception of the invention); see also Pro-Mold &
Tool Co. v. Great Lakes Plastics, Inc., 75 F.3d 1568, 1575 (Fed. Cir. 1996).
86 See Trovan, Ltd. v. Sokyamat SA, 299 F.3d 1292, 1304-05 (Fed. Cir. 2002).
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otherwise valid claims owing to the potential disconnect between technical language
and patent language, a gulf recognized by the Federal Circuit as discussed above.
The second great uncertainty lies in statements by the Federal Circuit
suggesting a contribution 8must
not only be made by the omitted inventor, but
"conceived" by that person. 7 This phrase, found in a number of cases but never
squarely endorsed by the court, could be read as nothing more than a statement that
Another interpretation,8 8
the contribution must be inventive in some sense.
however, is that "conception," means no more and no less than the formation in the
mind of the purported inventor of a mental image of the contribution as it would be
used in the invention as ultimately claimed. Under this interpretation, the supply of
a "lump of clay" would never, in itself, be an inventive contribution. While certainly
a permissible reading of the cases, this theory would ultimately seem to encourage
parties to stave off inventorship disputes through clever claim drafting rather than
encourage the public policy of encouraging "team research" at the heart of enacting
35 U.S.C. § 116.

a. The FirstStep ofAnalysis, Claim Construction,Is Never Entirely Certain.
The fact that both claim construction and inventorship are questions of law
likely informed the choice of the Federal Circuit to clarify in Trovan that the first
step in an inventorship analysis is claim construction.8 9 Per Trovan, once that is
accomplished the omitted individual's contributions are to be measured against the
claims as construed.90 In doing so, the Trovan court did not confront the reality that
claim language may or may not reflect the language chosen by the omitted
individual-or the named inventors, for that matter. 91 No one, apparently, felt
compelled to address how Solomon and Markman Is discussion of the disconnect
between named inventors and their patent counsel, might carry over to parties that
were not even part of the patent prosecution process.
This use of claim construction as the one means to get at the scope of the
invention for determining inventorship also seems misplaced as a matter of timing.
Conception necessarily predates the drafting of claims in final, allowable form. This
process may take years and multiple amendments, none of which an omitted
individual would be privy to. In view of Solomon, moreover, it is plain that there is a
distinct possibility that the invention may be subjectively "conceived" by the inventor
(whether named or not) in a manner that is very different from the final definition of
the invention found in the claims. 92 This protocol therefore places a purported
omitted inventor and ultimately the court considering a correction matter in the
position of first construing the claim as granted, then attempting to extrapolate
87 See Ethicon, Inc. v. U.S. Surgical Corp., 135 F.2d 1456, 1460 (Fed. Cir. 1998) (citing
Burroughs Wellcome Co. v. Barr Lab., Inc., 40 F.3d 1223, 1227-28 (Fed. Cir. 1994)).
88 First advanced, to the author's knowledge, by Donald Knebel, partner, Barnes & Thornburg
LLP, in 2005.
89 Trovan, 299 F.3d at 1302.

90 Id.

91 See Solomon v. Kimberly-Clark Corp., 216 F.3d 1372, 1379-80 (Fed. Cir. 1999) (quoting
Markman v. Westview Instruments, Inc. (Masrkman 1), 52 F.3d 967, 985 (Fed. Cir. 1995).
9i2Id.
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backwards from that construction and place those terms in the context of the
language employed at the time of the supposed contribution and determine if a
substantial contribution has been shown by clear and convincing evidence.
Trovan itself points to the problems with such an approach. One source of the
dispute was the alleged contribution of the attachment of 93wires to an integrated
circuit in a manner so as to provide support to the circuit.
The Federal Circuit,
having construed the term to require some measure of, but not sole, support, then
remanded for the lower court to determine exactly who contributed to this idea as it
found the prior record unclear. 94 However, what was left unaddressed was how this
interpretation of the claim term would or would not relate to the language employed
in the records of the named and purported inventors. Indeed, the case itself suggests
the panel was drawing a distinction the inventors and those associated with the
project did not. 95 Given that the subjective intent of the inventor is irrelevant to
claim construction, moreover, the court would arguably commit error in even
considering the materials the parties might have that would otherwise steer the
court to using the same language used in the course of the collaboration. 96 If the
dictates of cases such as Eli Lilly & Co. v. Aradigm Corp. were followed, any
deviation between the construed language and the language employed in the
materials purporting to prove the contribution could be used as a basis for denying a
97
true inventor relief.
While this may seem to favor the named inventor, the sheer unpredictability of
claim construction may encourage frivolous claims. No one at this late date could
argue that claim construction is a predictable and orderly application of legal
principles to particular facts. While the vision of both judges and all interested
parties applying the same principles of law to claim construction to arrive at
consistent, foreseeable results was central to the Federal Circuit's determination that
claim construction should be resolved solely as a matter of law, 98 the courts' handling
of claim construction issues are far more fractured. Additionally, given that the
93 Trovan, 299
94
9

F.3d at 1301, 1305.
Id. at 1306-10.

Jd. at 1306-7 n.i.

96 Solomon, 216 F.3d at 1379-80 (quoting Markman j

52 F.3d 967, 985 (Fed. Cir. 1995)).
Indeed, consulting such material would suggest that claims are to be construed like contracts rather
than statutes, the proposition rejected on bane by the Federal Circuit in Markman - -d. On the
other hand, it would be no less improper to consult the inventors' materials to ensure that the court
was using the correct language in context than considering the accused device to inform the claim
construction discussion-which has recently been endorsed by the Federal Circuit. Wilson Sporting
Goods Co. v. Hillerich & Bradsby Co., 442 F.3d 1322, 1327, 1330-31 (Fed. Cir. 2006); Lava Trading,
Inc. v. Sonic Trading Mgmt., LLC, 445 F.3d 1348, 1350 (Fed. Cir. 2006).
97 Eli Lilly and Co. v. Aradigm Corp., 376 F.3d 1352, 1358-59 (Fed. Cir. 2004).
98 See Markman , 52 F.3d at 978-79.
[Competitors] may understand what is the scope of the patent owner's rights by
obtaining the patent and prosecution history-'the undisputed public record'-and
applying established rules of construction to the language of the patent claim in
the context of the patent. Moreover, competitors should be able to rest assured, if
infringement litigation occurs, that a judge, trained in the law, will similarly
analyze the text of the patent and its associated public record and apply the
established rules of construction, and in that way arrive at the true and consistent
scope of the patent owner's rights to be given legal effect.
Id. at 979 (citation omitted).
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Federal Circuit, in Phillips v. A WH Corp.,99 has now indicated that a court may use
any relevant source of evidence in any order,10 0 and courts have suggested the
accused device can be considered as part of the discussion,101 it is plain that
reasonable minds can arrive at vastly different claim constructions for any given
purpose.
While parties are not permitted to twist language like a "nose of wax" on claim
construction, with meanings altering as the needs arise, the goals of the parties
necessarily inform their respective positions and focus in claim construction.1 02 This
is as true in inventorship disputes as any other context, although the pressures are
not necessarily the same as in a typical infringement claim. In an infringement
setting, the plaintiff/patentee is generally (but certainly not always) seeking a broad
"ordinary meaning" for claim terms and the defendant seeks a narrow meaning
drawn from the preferred embodiment in the specification. In inventorship disputes,
if the specification mentions the purported contribution specifically, it would behoove
the omitted individual to find a means plus function element to which the
contributions might be the corresponding structure. Ethicon would then provide a
roadmap to declaring the existence of co-inventorship. 103 An omitted co-inventor may
also want to generally broaden the scope of claim language to introduce the
possibility of alternative contributions. Of course, this might open the patent to
charges of invalidity on written description, best mode and similar issues by third
parties.1 04 To avoid this sort of possibility, and to ensure that the named inventors
are the only true inventors a party defending against a claim of co-inventorship
might be inclined to take a narrow view of claim scope-a strategy that might
ultimately limit or destroy the value of the patent in blocking competitors. Avoiding
such complications would obviously be in an inventor's best interest.

. What Does the ContributionHave To Be-A Lump of Clay, or a Finished
Statue?
If contributions to conception are all that matter and claim construction is to be
used to gauge those contributions, there is still a vexing question that should give
pause to all parties facing potential inventorship issues. On the one hand, the case
law is clear that a party need not conceive of the invention as a whole in order to be a
co-inventor.105 However, less clear is whether a contributor needs to "conceive" of
99 415 F.3d 1303 (Fed Cir. 2005).
10 See id. at 1324.
101 See Wilson Sporting Goods, 442 F.3d at 1326-27, 1330-31 (citing NeoMagic Corp. v. Trident
Microsystems, Inc., 287 F.3d 1062, 1074 (Fed. Cir. 2002)); Lava Trading,445 F.3d at 1350.
102 See Innova/Pure Water, Inc. v. Safari Water Filtrations Sys., Inc., 381 F.3d 1111, 1116-17
(Fed. Cir. 2004) (quoting White v. Dunbar, 119 U.S. 47, 51-52 (1886)).
103 Ethicon, Inc. v. U.S. Surgical Corp., 135 F.2d 1456, 1463 (Fed. Cir. 1998) ("The contributor
of any disclosed means of a means-plus-function claim element is a joint inventor as to that claim,
unless one asserting sole inventorship can show that the contribution of that means was simply a
reduction to practice of the sole inventor's broader concept.").
104 See, e.g., Pannu v. Iolab Corp., 155 F.3d 1344, 1351 n.5 (noting need for reconsideration of
best mode if other inventors added).
105 See, e.g., Fina Oil & Chem. Co. v. Ewen, 123 F.3d 1466, 1473 (Fed. Cir. 1997) ("One need
not alone conceive of the entire invention, for this would obviate the concept of joint inventorship.").
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659

anything beyond a general idea. 10 6 To put it in a different light, does the purported
co-inventor need to have the general intent that their contribution be used in solving
the overall joint goal, or the specific intent that his contribution be used in a
particular fashion as reflected in the claims?
The latter view, championed in the case of Eli Lilly & Co. v. Crabtree,107 stems
from statements in cases like Hess 0 8 and CaterpillarInc. v. Sturman Industries,
Inc. 10 9 that the party in question failed to establish a "conception" of some kind.
Similarly, in Stern v. Trustees of Columbia University ° and American
Bioseienee,111 the court noted the lack of conception on the part of the purported
inventors as one factor in rejecting the claims. 112 Judge Newman has gone farther
than this and suggested that a failure to ever arrive at a conception of the final
invention (assumedly not the first, per Fina Oil), should remove any question of coinventorship. 113 However, the former comments have not been central to the
determination of any case, and Judge Newman's comments were voiced in dissent.
Therefore, the question remains whether a collaborator has to be aware of how his or
her contribution would fit in the final invention in order to make a substantial
contribution to the conception of the invention.
This may seem like idle speculation, but consider a hypothetical. A doctor has a
general idea that she would like to countersink a bone screw so that it is braced by
and flush with a plate. She collaborates with a biomedical engineer who recognizes
that a variety of methods may be employed. If the engineer provides a previously
known plate and screw assembly, even if it is in an overall novel combination, then

106 See id. at 1473 (stating the general rule that "a joint inventor must contribute in some
significant manner to the conception of the invention."); Burroughs Wellcome Co. v. Barr Labs., Inc.,
40 F.3d 1223, 1229 (Fed. Cir. 1994) ([E]ach inventor must contribute to the joint arrival at a
definite and permanent idea of the invention as it will be used in practice" without specifying a
conception in the mind of the contributor.); ef Hess v. Advanced Cardiovascular Sys., Inc., 106 F.3d
976, 981 (Fed. Cir. 1997) ("Mr. Hess's contributions to the inventions did not constitute the
conception necessary to establish co-inventorship."); Bd. of Educ. v. Am. Bioscience, Inc., 333 F.3d
1330, 1340 (Fed. Cir. 2003) ("invention does require conception, and there is no evidnen that FSU's
inventors conceived any of the claimed compounds. Having in mind specific portions of a claimed
compound is not the same as conceiving the compound with all of its components."). Note, however,
that American Bioscience was in the context of the FSU scientists claiming sole inventorship, rather
than contribution to joint inventorship with the named inventors. Id. at 1336-37.
107224 F. App'x 962 (Fed. Cir. 2007), afFg 485 F. Supp. 2d 982 (S.D. Ind. 2006). The author
played a significant role in drafting the successful summary judgment briefing on this issue and Eli
Lilly & Co.'s response brief on appeal based in part on discussions regarding the necessity of
"conception" of a contribution with Donald Knebel.
108 Hess, 106 F.3d at 981 ("Mr. Hess' contributions to the inventions did not constitute the
conception necessary to establish co-inventorship.").
10) 387 F.3d 1358, 1379-80 (Fed. Cir. 2004) ("We conclude that the district court clearly erred
in finding that ... Mr. Sturman presented clear and convincing evidence that he also conceived the
idea of [the invention]."). Again, this arose in the context of a sole, rather than joint, inventorship,
claim, so the scope of the statement is unclear. Id.
110434 F.3d 1375, 1378 (Fed. Cir. 2006).
111 Am. Bioscience, 333 F.3d at 1340.
112 Id,

113 PerSeptive Biosystems, Inc. v. Pharmacia Biotech, Inc., 225 F.3d 1315, 1323-24 (Fed. Cir.
2000) (Newman, J., dissenting).
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Aeromed Corp. v. Sofamor Danek Group, Inc.114 and Hess'1 5 would indicate the
engineer is not an inventor. If the engineer suggests a novel structure, though, and
it is described in the written description and a means plus function element relates to
it, Ethicon1 16 would support a finding of inventorship. But if the claim recited a bone
plate specifically for spinal applications, and the engineer had only conceived of his
apparatus for use in long bone treatments, the question arises as to how to treat the
contribution. A strict reading of Fina Oilmight suggest the lack of a "joint arrival" at
the final invention and hence no joint invention, as by the time of the final invention
the engineer's vision had been bypassed.11 7 At the same time, there is no doubt in
this hypothetical that the novel structure was a significant contribution to the final
118
invention and would hence meet the other definition in Fina Oil and similar cases.
Hence, the question remains whether a contribution to conception must itself be
accompanied by a conception on the part of the contributor that can be found in the
final claim.
Case law has not provided a satisfactory solution to date, and strong arguments
exist on both sides. On the one hand, failing to require a mental impression of the
actual contribution as ultimately claimed might open a Pandora's Box of potential
inventors and raise questions such as: does every sort of facilitation of a collaboration
including the provision of supplies, the procurement of samples or oversight
management and scheduling merit inclusion as an inventor?; where does the line get
drawn? Similarly, setting the bar too high for a definitive mental definition of the
contribution reflected in the claims may provide a perverse incentive in claim
drafting. It would be in the best interest of applicants to craft an application to fully
disclose the contribution of an unnamed party, then claim in a way that differed from
the party's contribution as provided/conceived. Plainly, such a result would not
further the public policy underlying the passage of section 116 and "team research,"
but parties seeking to avoid including minimal contributors as co-owners might very
well see such a path as worthwhile. This uncertainty should, yet again, encourage
parties to take all steps necessary to avoid inventorship disputes, as this highly
subjective area could tilt a close case.

M'253 F.3d 1371, 1381 (Fed. Cir. 2001) (holding that although the combination of old elements
was patentable, there was not sufficient evidence to support that an individual's contribution of one
of the old elements was an inventive conception, and thus he was not a co-inventor).
"15 Hess v. Advanced Cardiovascular Sys., Inc., 106 F.3d 976, 980-81 (Fed. Cir. 1997) (holding
Mr. Hess' contributions to the inventions, specifically, suggesting a particular product, teaching how
it could be used, and making other suggestions about how to make the invention, "did not constitute
the conception necessary to establish co-inventorship").
116 Ethicon, Inc. v. U.S. Surgical Corp., 135 F.3d 1456, 1464 (Fed. Cir. 1998) (noting there was
not sufficient evidence to show that an individual's contribution "was simply a reduction to practice
of the broader concept of using any detaining means commensurate with the scope of [the] claim,"
and thus that individual was entitled to co-inventor status).
117 Fina Oil & Chem. Co. v. Ewen, 123 F.3d 1466, 1473 (Fed. Cir. 1997).
118 Id.
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C. Certain Actions, StandingAlone, Are Never Inventive.
While the foregoing illustrates the difficulties inherent in all inventorship
disputes, there are, fortunately, a number of certainties. The case law has provided
enough guidance to state that particular conduct, even if corroborated, is not
inventive. While that is plainly less comforting than any attempt at categorizing
what is inventive, at least it permits companies and practitioners some measure of
security about what actions can be taken without risk of co-inventorship claims
arising. Note, however, that these actions have ordinarily been analyzed in isolation
of other factors, so it is less clear how a combination of such acts along with other
indicia of inventorship might be viewed.
Perhaps the most obvious condition that isnot inventive is a contribution by a
party with no knowledge of the ultimate project. 119 Hence, a person may be called on
to provide advice as to a discrete problem or aspect of a development without
becoming an inventor so long as he or she is not aware of the target of the research.
Hence, vendors and consultants would not ordinarily be inventors. Similarly, under
the dominant paradigm for assessing inventorship, contributions that are not
reflected in the issued claims cannot support a finding of inventorship. 120 At the
same time, as shown by PerSeptive Biosystems, it is incumbent on applicants to be
scrupulous in how such interactions are described to avoid the specter of inequitable
121
conduct allegations.
Similar to the unknowing consultant is the one who simply provides knowledge
or skill known to persons of ordinary skill in the art. This is again linked to the
O'Reilly v. Morse and Hess line of cases, which seek to avoid rewarding parties whose
contributions theoretically could have been gleaned from any competent source in the
art, including prior art references as well as consultations with such individuals. 122
Related to this consultation idea as well is the idea, endorsed in Stern, Caterpillar
and Sewall, that merely providing the skill set of a person of skill in the art in
carrying out the directions of another is not inventive. 123 As discussed below, in the
context of corporate collaborative efforts this can be a tough line to draw, both
because it can be hazy as to how much direction was given and the natural
inclination of parties to want to be inclusive as a way of building camaraderie or
1") See, e.g., Ethicon, 135 F.3d at 1460 ("One who simply provides the inventor with wellknown principles or explains the state of the art without ever having 'a firm and definite idea' of the
claimed combination as a whole does not qualify as a joint inventor.").
120 See Bd. ofEduc. v. Am. Bioscience, Inc., 333 F.3d 1330, 1342 n.7 (Fed. Cir. 2003).
It is conceivable, although we express no opinion on that matter, that other
persons may have had an inventorship role with respect to the subject matter that
was cancelled. Nonetheless, it is the granted patent with the limited claims that is
before us, and any possible inventorship with respect to the cancelled claims is not
at issue here.

Id.
121

PerSeptive Biosystems, Inc. v. Pharmacia Biotech, Inc., 225 F.3d 1315, 1320-22 (Fed. Cir.

122

See Hess v. Advanced Cardiovascular Sys., Inc., 106 F.3d 976, 981 (Fed. Cir. 1997) (quoting

2000).

O'Reilly v. Morse, 56 U.S. (1 How.) 62, 111 (1853)).
123 Stern v. Trs. of Columbia Univ., 434 F.3d 1375, 1378 (Fed. Cir. 2006); Caterpillar Inc. v.
Sturman Indus., Inc., 387 F.3d 1358, 1377-78 (Fed. Cir. 2004); Sewall v. Walters, 21 F.3d 411, 416
(Fed. Cir. 1994).
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team unity. Nonetheless, merely serving as the "pair of hands" for the real inventor
is not itself inventive.
Because of the emphasis placed on conception, the case law has also made it
clear that simply carrying out that conception through the application of skill in the
art is not sufficiently inventive. This extends to either the actual execution of a
design or confirmation of usefulness of an invention. For example, in both Sewall
and Acromed, the putative inventor was found to have simply executed on the
conception of another. 124 As mentioned above, Pannu and American Bioscience
suggest an exception might exist for actions that effectively make the conceived
invention possible. 125 However, no case has ever proven inventorship on such a
basis, so a well-documented conception should generally end the claim of any person
whose conduct came after that date.
Similar to the execution of a design is the proof that the invention is useful.
Such steps are necessarily important to commercial exploitation, but are not
inventive if they come after conception. For example, as recited in Burroughs
Wellcome Co. v. BarrLabs., Inc, 126 the National Institute of Health ("NIH") was the
first to conclusively establish that azidothymidine ("AZT") had an inhibiting effect on
the HIV/AIDS virus. 127 However, before it ever submitted its AZT samples to the
NIH, Burroughs Wellcome had conceived its use as an HIV inhibitor, conducted some
limited testing and had even filed a British patent application setting forth a variety
of potential uses. 128 In the face of such clear evidence of conception, the proof of the
129
compound's utility was not inventive.
Finally, merely being entangled in the same project or the same field is not
inventive of a particular invention. While this may seem simple, a reputation of
dominance in the field of taxol research was the primary basis for a district court to
13 0
name a Florida State University professor an inventor in American Bioscience.
Similarly, in Trovan, a party who was the named inventor on one patent attempted
to rest his claim of inventorship in a second patent on the "common subject matter" of
the two. 131 Similarly, claims have been predicated on ownership agreements or the
inclusion of a putative inventor as a contributor to group publications. 132 While any
of these may be some evidence of corroboration of an otherwise inventive
contribution, the case law has found these acts are not themselves adequate to
124 Sewall, 21 F.3d at 416; Acromed Corp v. Sofamor Danek Group, Inc., 253 F.3d 1371, 1380
(Fed. Cir. 2001).
125 Pannu v. Iolab Corp., 155 F.3d 1344, 1351 (Fed. Cir. 1998); Am. Bioscience, 333 F.3d at
1342.
126 40 F.3d 1223, 1230 (Fed. Cir. 1994).
127 Id.
128 Id.

129

Id.

Am. Bioscience, 333 F.3d at 1341 ("Much of FSU's appeal brief is devoted to extolling
Holton's scientific accomplishments, the implication being that he must be an inventor of the three
claimed compounds.").
131 Trovan, Ltd. v. Sokymat SA, 299 F.3d 1292, 1303-04 (Fed. Cir. 2002).
132 Sewall v. Walters, 21 F.3d 411, 417 (Fed. Cir. 1994) (rejecting alleged representations of
ownership as inapposite to question of inventorship); Gemstar-TV Guide Int'l, Inc. v. Int'l Trade
Comm'n, 383 F.3d 1352, 1382-83 (Fed. Cir. 2004) (rejecting assertion of corroboration from product
descriptions that named putative inventor but did not specify particular contributions to the
invention).
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establish inventorship. Hence, if all a claimant has is a reputation in the field or a
patent on something similar, the claim should be rejected at the summary judgment
stage at the latest.

III. COMMON PROBLEM SCENARIOS AND How To AVOID THEM

One fairly effective way to avoid co-inventorship problems is to lock all potential
creators of inventions in individual cells with no contact with the outside world. Like
never plugging a computer into a network to avoid viruses, though, this cure is likely
worse than the disease as it would likely destroy, rather than encourage creative
output. It is also likely illegal in several states as a form of false imprisonment and
violation of workplace regulations. Therefore, collaborative relationships are going to
be formed, creating the potential for inventorship disputes.
Four scenarios often give rise to questions regarding inventorship. Each creates
slightly different potential pitfalls and suggests various steps that can minimize
inventorship issues. First, a company may develop an invention entirely in-house,
which is unlikely to result in a claim as long as all inventors are still employed by the
company, but may set the stage for problems after any omitted or improperly
included party leaves the company. In the second scenario, when companies
collaborate, each is often sensitive to issues of protecting their existing confidential
information, but not always as cognizant to define the collaboration and address
ownership of the results. There also is a tendency for both sides to draft any patent
applications without consultation of the other party, which can result in disputed
information being patented. Third, when companies reach out to academics, the
clash of the scientific model of open discussion and the private sector concern with
protecting intellectual property can result in a number of misunderstandings and
seemingly conflicting representations in documents and publications, which can later
give rise to sharp disputes over who really did what after the fact. Finally, the
relationships of students and mentors in academic settings are a fertile ground for
claims of misappropriation or nonjoinder if the parties do not make their interests
and intent clear from the outset of the relationship.

A. Intra-CompanyCollaborations- The GreatestPossible Control, but Still
SignificantPotentialfor Errors.
Intra-company collaborations are precisely the sort of "team research" that
section 116 was amended to cover. While many hands make light work, and team
building is at the core of many business philosophies, adhering to inventorship
standards imposes a calculus that many employers might find troubling. In the
realm of scientific publications, this is solved by giving co-authorship credit to
everyone associated with a project leading to a scientific paper in the name of "team
133
science." This may be acceptable in the academy, and that is a matter of debate,
but the term for it in patent parlance is "misjoinder." Likewise, while a failure to
133See Donald Kennedy, Multiple Authors, Multiple Problems, SCIENCE, Aug. 8, 2003, at 733
(noting the legal and practical dilemmas inherent in joint authorship of academic research papers).
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give credit properly on a publication might create tension in an entity, naming too
few individuals and hence committing nonjoinder may limit or ruin the commercial
value of a patent.
To date, misjoinder has not posed a significant threat to patent-holders. Where
truly erroneous inventorship has been present, it has typically arisen in the context
of outright theft or misappropriation such as Frank's Casing Cew1 34 and University
of Colorado Foundation.135 The latter case, as detailed above, led to an award of
damages; the former, led to a finding of unenforceability. By comparison, an honest
13 6
mistake or dispute as to inventorship should not lead to such findings.
Nonetheless, allegations of intentional misjoinder are easy to envision, and
difficult to avoid in the right circumstances. For example, assume that a design team
tenders an invention disclosure form. The corporation, per policy, lists all members
of the team as inventors, and has each sign an oath to that effect, without ensuring
who contributed what. As a result, despite a number of changes in prosecution the
named inventors remain the same throughout. Only after departing the company
does a team member, now working for a rival, claim that in fact he or she knew that
his or her sole contribution was administrative but signed the oath anywayperhaps, for example, to net a year-end bonus or merely to protect their internal
status.
A lack of proper investigation can also lead to nonjoinder. Often times, the party
leading a team is responsible for submitting reports and invention disclosures, but
may not know exactly who did what. If help was provided from sources outside the
immediate team, moreover, there may be a pressure to downplay or eliminate
reference to those sources. When the omitted employee discovers the error, it may
prove to be in his or her best interest to assert co-inventorship status.
If this seems far-fetched, consider the case of Checkpoint Systems v. All-Tag
Security SA.137
In this case, three individuals (two corporate officers and a
consultant) had consistently indicated that the consultant, who assigned the patent
to Checkpoint, was the sole inventor.1 38 Subsequently, one of the declarants formed
and eventually sold All-Tag, and at various times employed the consultant.1 39 When
Checkpoint later sued All-Tag, All-Tag obtained summary judgment based largely on
statements of the three declarants that inventorship was incorrect.1 40 The Federal
Circuit ultimately reversed and remanded the issue of inventorship for trial, but
nonetheless found the flatly contradictory statements were sufficient to create a

13 Frank's Casing Crew & Rental Tools, Inc. v. PMR Techs., Ltd., 292 F.3d 1363, 1376-77
(Fed. Cir. 2002) (holding patent acquired by individuals lacking legitimate inventorship claim was
unenforceable even if inventorship corrected).
15 Univ. of Colo. Found., Inc. v. Am. Cynamid Co., 342 F.3d 1298, 1302-03 (Fed. Cir. 2003)
(describing copying of article by true inventors into application naming American Cyanamid
employee as sole inventor).
136 See, e.g., PerSeptive Biosystems, Inc. v. Pharmacia Bio-Tech., Inc., 225 F.3d 1315, 1321
(Fed. Cir. 2000) (noting that the basis for ruling was not a good faith disagreement over
inventorship).
137 412 F.3d 1331 (Fed. Cir. 2005).
138 Id.
at 1333-34.
139 Id.
at 1334.
140 Id. at 1335-36.
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question of fact. 141 There is no doubt that there are former employees with better
cases out there-it is simply a matter of time before their cases come to light.
So, what is a conscientious in-house or outside patent counsel to do? Initially,
make sure every employee understands their rights and responsibilities vis-a-vis the
company. Make it company policy that any inventions relating to the company's
business or the employee's job duties, as well as anything created using company
time or resources, is automatically subject to a duty of assignment. This will at least
minimize some of the incentive to "remember" inventing something later. In drafting
such a policy, it is not wise to assume inventions will always come from the research
and development process-they may be improvements in production processes,
business methods, or simply ingenious ways to address seemingly mundane tasks.
Remember, Post-Its were developed by a secretary at 3M almost by accident.
In keeping with this broad understanding of the entity's ownership interest and
potential sources of intellectual property comes a need for employee education on the
basics of inventorship. It needs to be explained that invention requires something
more than showing up for the team picture and something less than inventing a cure
for cancer all by yourself. This should be coupled with requiring, as part of the initial
invention disclosure process, as much detail as possible about who did what, so that
in drafting the initial application counsel can make a somewhat enlightened
evaluation of inventorship on a claim by claim basis.
This effort cannot end here, although it does at many entities. When the claims
are changed in any significant manner, it may be necessary to re-evaluate
inventorship. Under the general rule that inventorship is exclusively measured by
the issued claims, 142 the cancellation of claims should also be of special concern. If
nothing else, once the examiner has indicated allowance, counsel should make an
effort to verify that the claims that will issue name no more and no less than the true
inventors.
One effective method for ensuring the involvement of employees and
documenting the understanding of the individuals in question at the time of
invention is to break the claim elements out into a grid or chart. 143 The members of
the team can then be asked to indicate who did what, either limited to their own
actions or inclusive of the team of the whole. Conflicts or blank spots then suggest
areas to follow up on and get further information, whereas the collective documents
also create a solid record to counteract later versions of events.
This sort of effort is apt to be unpopular with some employees, especially at
companies that do not provide monetary incentives for patents. While linking
monetary awards directly to patents creates an incentive for compliance, it also
creates an incentive to cut others out of the process. An alternative is to provide
rewards for ingenuity and improvements, without linking them directly to the
issuance of a patent. By making compliance with patent procedures a component in
evaluating performance relative to such rewards, though, the entity could create an
incentive to obtain the information necessary to a comprehensive evaluation without

Id. at 1338-39.
See Bd. ofEduc. v. Am. Bioscience, Inc., 333 F.3d 1330, 1342 n.7 (Fed. Cir. 2003).
The author first saw this technique in a document prepared by Ronald Henderson, partner,
Barnes & Thornburg LLP, while Mr. Henderson was working as in-house counsel for a large entity.
141

142
143
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creating the same perverse incentives to omit potential inventors to benefit one
party.
Ultimately, a company's success in avoiding inventorship issues with its own
employees is largely a matter of communication and emphasis. Entities that
understand the importance of patents will also tend to understand the need for good,
clear records of inventorship. Those who do not understand, seek patents at their
peril.

B. Inter-Company Collaborations-ClarifyingIntentions and Ownership Is Key
At some point, every corporate entity will find itself addressing problems with
persons other than its own employees. Whether in an overt joint development or
informal discussions with vendors and customers, just about any interaction may
give rise to a patentable innovation. Similarly, the difficulties associated with
ensuring proper inventorship and ownership of the resulting patent can intrude and
create difficulties in future interactions or suits to enforce the patent against third
parties.
As with intra-company collaborations, one of the key issues is understanding the
breadth of circumstances that can give rise to an inventive collaboration. No matter
how far-fetched the possibility seems, companies should take efforts to clarify their
position with any person or entity allowed on the premises. Companies are typically
sensitive enough to request non-disclosure agreements, but less common is to clarify
the parties' position regarding intellectual property.
If an attempt is made,
moreover, it is often limited to discussions of ownership and duties to prosecute,
rather than addressing any issues regarding a party's position on inventorship.
To the extent possible, parties should eliminate this blind spot in their approach
to collaborations. If a company has appraised its employees of how to deal with
potential inventions and inventors on internal projects, it should not be difficult to
similarly inform potential collaborators. If a company routinely seeks patents and
will aggressively do so in all phases of its operations, there is nothing wrong with
putting others on notice of this fact.
If the company has a policy of only
disseminating patent applications to named inventors, that too should be made clear.
In this manner an allegedly omitted inventor's claims of ignorance of the process
involved or the entity's interests as a basis for tolling the statute of limitations are
undercut.
It is also generally in a party's interest to enter into a formal joint development
agreement wherever it appears likely an innovative process, method or product will
result. This would not only be in the context of pure research projects but also in
applied problem solving. While adopting a policy of entering such agreements will
not guard against the unforeseeable breakthrough, and may slow down some projects
initially, it will provide a framework for understanding how patent issues, and
specifically inventorship, will be handled. The existence of a joint development
agreement will also prevent the use of either side's private prior work on the subject
matter of the collaboration from being asserted under as part of an obviousness
claim. 144
144

See 35 U.S.C. § 103(c)(2)-(3) (2006).
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Upon entering such a joint development or similar collaboration, monitoring and
record-keeping become critical. Some might look at the result in Eli Lilly v. Aradigm
and suggest that the best way to avoid inventorship disputes is to keep no records at
all. 145 However, this overlooks the fact that good records of inventorship may avoid
litigation in the first instance and in any event are more apt to result in summary
judgment or a trial verdict in a party's favor. Moreover, in the absence of an
agreement that only one party can seek a patent on the subject matter of the
collaboration, there is no way of telling in advance which party may be placed in the
position of proving inventorship by clear and convincing evidence.
As with the purely intra-company situation, in the event one side identifies a
potential innovation it becomes important to clarify who thinks they contributed to it.
If it is apparent that despite the collaborative nature of the project only one side truly
acted inventively there is no legal obligation to provide the other side access to the
patent application or otherwise notify them of the prospect that a patent may issue.
However, even in this situation it would be advisable to get some sort of consent from
the other side acknowledging the disclosure and waiving any claim to disclosed
invention, setting up an estoppel defense. 146 As the best way to ensure such an
agreement can be obtained is by providing clear documentation of just who
contributed what and how, this again argues in favor of detailed record keeping.

C. Corporate-AcademicCollaborations--AvoidingInformality
and Clarifying Ownership
Several prominent inventorship cases center on the interaction of academic or
non-profit institutions with corporations. 147 Although many universities have
become more sensitive to the value of patents and innovations generally (as shown in
the creation of private licensing companies or business incubators affiliated with the
academic institution) this does not necessarily translate to a higher level of
sensitivity among academics regarding the value of patents. As noted above, the
academic impulse is often to be over-inclusive on collaborative publications so as to
ensure that all receive credit for the project. Such an attitude, while noble, could
prove fatal to obtaining a meaningful, valuable patent. Hence, such collaborations
are ones in which all parties with a financial interest in the outcome would do well to
ensure that the researchers understand the different standards for academic credit
and inventorship.
The collegial spirit reflected in naming all participants as authors creates
another problem for inventorship. Academic institutions and parties collaborating
with them often work on a fairly informal basis, without documenting many steps or
ensuring that a particular task has been approved under the joint development
agreement. However, a joint development agreement only shields inventions from
certain types of obviousness challenges if the invention arises from the written
subject matter of the joint development agreement, so general collaborations will not

145 Eli Lilly & Co. v. Aradigm Corp., 376 F.3d 1352 (Fed. Cir. 2004).
146 See MCV, Inc. v. King-Seeley Thermos Co., 870 F.2d 1568, 1571-74 (Fed. Cir. 1989).
147 See e.g., Univ. of Colo. Found. v. Am. Cyanimid, 342 F.3d 1298 (Fed. Cir. 2003).
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have this protection. 148 Similarly, on the issue of inventorship the lack of formality
can make determinations as to contributions to conception very difficult to measure.
Ultimately, though, the biggest issue in such collaborations is ensuring the
academic institutions involved understand the fact that a patent is likely to be
sought on anything they develop or help to develop. One of the interesting factual
aspects of the University of Colorado case is that the actual inventors had no
apparent intent to seek a patent, but rather were simply planning on publishing
their findings in a medical journal. 149 There is little doubt that the $53 million
subsequently awarded to the University of Colorado Foundation far exceeded any
license that entity might have required of American Cyanimid. This award
effectively eliminated American Cyanimid's profits from the patent, something no
license would have done. Given this alternative, there simply is no downside to
honestly apprising a party of the intent to seek patents, particularly where there is
reason to believe the other side does not routinely engage in patent practice and if
the private entity is funding the research in question. Documenting this also makes
it much more difficult for the academic institution to assert that any sort of fiduciary
responsibility was created or that the private entity owed some duty to inform the
academic institution of its patent activities.
In contrast with development operations, one other source of significant
corporate interaction with non-profit organizations and universities is in viability
studies or testing. In this context, Burroughbs Welleome lays out the key to avoiding
improper claims of inventorship. 150 There, the party did what it could before
enlisting the NIH to ensure AZT was useful for inhibiting HIV/AIDS.151 By filing a
patent application before involving the NIH, Burroughs Wellcome could indisputably
show conception and a reduction to practice (albeit a constructive one).152 While this
would be an unnecessary expense every time a collaboration is about to be entered,
making such a filing or otherwise creating a fixed record of the status of a project
before the introduction of a collaborator makes sense anytime one party has made
substantial investments in a project prior to introducing a second party to the
remaining issues.

D. Students and Mentors-DistinguishingInstruction and
Assistance from Invention
The student-teacher relationship is inherently one of trust, especially in the
context of advanced research.
Students trust their instructors to serve as
professional mentors and help shape their careers. Research professors similarly
trust their students to execute assigned tasks and use the best of their abilities to
attempt to further large scale goals. A failure by either can result in disastrous
consequences to reputation and the research at issue.

35 U.S.C. § 103(c)(2)-(3).
Univ. of Colo. Found., Inc., 342 F.3d at 1302-03.
150 Burroughs Wellcome Co. v. Barr Labs., Inc., 40 F.3d 1223, 1230 (Fed. Cir. 1994).
151 Id. at 1230.
152 Id. at 1230-31.
148
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The historic measuring stick for academic institutions and professors was
publications, not patents. However, the growing sensitivity of academic institutions
to the value of patent rights has also made research resulting in patents of value to a
student and/or professor's value. In doing so, however, the system may create
incentives for each party to a collaboration to overstate their role, either to assist in
furthering their careers or strictly for pecuniary gain. Cases such as Chou, American
153
Bioscience and Stern all speak to the powerful nature of such incentives.
In the first instance, therefore, the institution must make an effort to be as
professional with students performing lab work as it would be with other employees.
While the institution may have a uniform patent policy, it must endeavor to ensure it
is communicated clearly to all students. To minimize the risk of future disputes, the
ownership position of the institution and its criteria for assessing inventorship
should be made clear.
Like most sizeable companies, moreover, disconnects tend to develop between
academic institutions' legal personnel and persons who actually engage in research.
To avoid this, it would be advisable to request quarterly or at least biannual updates
on research projects, including any developments that may be ready for patenting.
Many grant agencies require such reports as it is, so this should not be an undue
burden on these institutions. As discussed above in the context of companies, such
efforts would create a better documentary record than is often currently available for
assessing conception and reduction to practice as well as the value of individual's
contributions.
The major focus of much academic research is, and likely will continue to be, the
issuance of academic papers. To the extent the impulse to include all pertinent
researchers as "authors" cannot be checked, it would make these articles much more
valuable in the context of inventorship if they accurately depicted the contributions
of the various parties to the greatest degree possible. Hence, if a particular example
was run by a researcher, out of many similar such tests, credit should be given where
due in explicit terms, rather than to the team as a whole. Unless and until papers
begin to reflect that reality, they will be of little to no use on their own in assisting
with inventorship issues.
Even such convoluted articles may indirectly assist in creating a solid record of
inventorship, however. One of the obvious triggers for filing a patent application is
the submission of a work for publication, as the resulting publication will form the
basis of a 102(b) bar to obtaining a patent. 154 A similar concern exists with "poster
presentations" and similar less permanent works in light of In re Kopfenstein.155 In
making a legal review of either the publication or other materials to determine if an
153 Chou

v. Univ. of Chi., 254 F.3d 1347, 1359-60 (Fed. Cir. 2001) (noting that each defendant

has an economic stake in the validity of the patents at suit, and hence the correct designation of

inventors ); Bd. of Educ. ex re] Bd. of Tr. of Fla. State Univ. v. Am. Bioscience, Inc., 333 F.3d 1330,
1338 (Fed. Cir. 2003) (noting that "because the issuance of a patent creates a presumption that the
named inventors are the true and only inventors, the burden of showing misjoinder or nonjoinder of
inventors is a heavy one and must be proved by clear and convincing evidence"); Stern v. Trs. of
Columbia Univ., 434 F.3d 1375, 1378 (Fed. Cir. 2006) (noting that contribution to one claim is
sufficient to be a co-inventor, and thus have an ownership interest in the patent).
154 35 U.S.C.
155 380 F.3d

§ 102(b) (2006).
1345, 1350-52 (Fed. Cir. 2004) (finding that poster presentations qualified as
"printed publications" for purposes of 102(b) bar).
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invention is disclosed, the academic institution should also strive, just as a company
would with an invention disclosure form, to determine who actually did what and
how important that contribution was. While the resulting record is apt to be
privileged and hence unlikely to be produced in most cases, it could be invaluable in
avoiding or minimizing the risk of incorrect inventorship and fending off baseless
claims.
To further minimize the risk of either over or under-appreciating the
contributions of students, when a patent application is drawn up it could and should
be circulated to as many identifiable participants in the study or research as possible,
rather than just the named inventors. This could be done by review of the research
reports as well as academic papers. Again, the actual process could mirror that of
private entities, with a grid allowing the person to identify what they believe they
contributed along with any documentation of the same. It could also be accompanied
with a declaration of no contribution, so as to create a record to support a defense of
estoppel. Owing to the transient nature of students, this might impose a greater
burden on the institution, but one which pales next to the cost of a trial. This would,
if nothing else, start the statute of limitations running in most states and likely
create a basis for asserting laches or estoppel as to any state law claims, hence
decreasing the odds of an adverse damage award.

IV. CONCLUSION
Inventorship is a thorny issue with few clear rules. The increasing value of
patents and the increasing appreciation of that value are likely to fuel ever more
inventorship disputes in the future. However, taking simple steps-the most
important of which is being forthright about the intent to seek a patent-will go a
long way in either avoiding or at least minimizing the risk that such a dispute will
lead to disastrous consequences for any person or entity.

